Insider Cluster (2 insiders) ·Filed Jul 9, 2026

CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $1.7M total
Actionable Insight • Neutral

Insider selling is persistent ($1.9M in 30d) but small relative to market cap. CEO Toy's $1.67M sale is routine diversification at these levels — not a strong bearish signal per academic literature. Monitor for any upcoming earnings or operational catalysts that might explain the selling pattern; absent such, treat as noise.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+20d
CLOV ▼ -0.43% at T+20d
NEUTRAL call ✗ call lost -0.43% · α vs SPY -2.67% · entry $4.68 → $4.66
Next anchor: T+60d due yesterday
Latest observation: T+57 -79.57% FF3 residual α
Entry anchored
Jul 8, 03:59 PM ET
via exchange tick
T+1d
-5.13%
call -5.13% · α -5.56%
$4.44
settled 3mo ago
T+5d
-5.98%
call -5.98% · α -5.85%
$4.40
settled 3mo ago
T+20d
-0.43%
call -0.43% · α -2.67%
$4.66
settled 8w ago
T+60d
—
call — · α —
—
due yesterday

Price Chart

Loading chart...

Executive Summary

Two Clover Health insiders sold a combined ~$1.68M in stock over a 7-day window. CEO Andrew Toy sold ~$1.67M at ~$5.32 on July 1, and Medicare Advantage CEO Jamie L. Reynoso sold ~$43.9K across two smaller trades at $5.26 and $4.68. The CEO sale is 0.07% of the $2.5B market cap — modest in size — and the other is trivial. No cluster of buys offsets these sales, and the timing does not appear tied to a specific catalyst.

Key Financial Metrics

Direction
selling
Total Value
$1.7M
Insiders
2

Key Facts

  • CEO Andrew Toy sold 313.5K shares for ~$1.67M on July 1, 2026 at $5.32.
  • Medicare Advantage CEO Jamie L. Reynoso sold 6.2K shares at $5.26 and 2.4K shares at $4.68, total ~$43.9K.
  • Total insider sales of ~$1.68M represent ~0.07% of $2.5B market cap.
  • No insider purchases occurred during the 7-day window.
  • Recent trading (30d) shows 8 sells totaling $1.9M — consistent pattern of insider selling.

Financial Impact

Combined insider sales of ~$1.68M (~0.07% of $2.5B market cap)

insider ownershipstock sentiment

Risk Factors

  • CEO selling 313K shares in a single transaction could be perceived negatively by retail traders.
  • Persistent insider selling without purchases may signal management caution about near-term fundamentals.

Market Snapshot

Exchange
Nasdaq
Sector
Hospital & Medical Service Plans
Analyst Consensus
60% bullish (10 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CLOV-1783670810125
18 reports for CLOV
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+5▲ +2.36%Aug 17, 2026
Filters
Rows
Reports for CLOV — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 2/10
$4.56 $4.57▲ +0.22%▼ −2.34%$4.41 (−3.40%)
Aug 17, 2026
6w ago
Insider Cluster
BEARISH ★ 5/10
$4.23 $4.13▲ +2.36%▲ +2.16%$4.41 (−4.14%)
Aug 11, 2026
7w ago
Court Ruling
NEUTRAL ★ 4/10
$4.39 $4.23▼ −3.64%▼ −3.24%$4.41 (+0.34%)
Jul 20, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.79 $4.27▼ −10.86%▼ −9.63%$4.41 (−8.04%)
Jul 17, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.68 $4.40▼ −5.98%▼ −5.85%$4.41 (−5.88%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$5.00 $4.82▼ −3.60%▼ −4.15%$4.41 (−11.90%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$4.80 $5.21▲ +8.54%▲ +9.58%$4.41 (−8.23%)
Showing 10 of 18

US Market Status

Market Open — Closes in 3h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 10, 2026